Class I major histocompatibility complex (MHC)-restricted CD8 + T cells have been demonstrated to be effective mediators of both acquired and adoptive immunity to the intracellular bacterium Listeria monocytogenes. We have recently determined that L. monocytogenes-infected H-2 a mice recognize a nonamer peptide, residues 91-99, of the secreted protein listeriolysin O (LLO), in a H-2Kd-restricted fashion. In this report we have generated CD8 + T cell lines with specificity for LLO 91-99 in the context of H-2K a by in vitro stimulation with P815 (H-2 a) cells transfected with LLO. These CD8 + lines have been generated from immune donors after sublethal infection with L. monocytogenes, or after in vivo immunization with syngeneic spleen cells coated with synthetic LLO 91-99 peptide. LLO-specific CD8 + T cells derived from either protocol were capable of significant protection against L. monocytogenes infection. The in vivo protection by these CD8 + T cell lines has been shown to be solely due to recognition of LLO 91-99 in the context of H-2K a. These studies demonstrate that CD8 § T cell immunity to a single, naturally produced peptide epitope has the potential for significant protection in a bacterial infection. Thus, the allele-specific motif approach to epitope prediction has identified a naturally produced bacterial epitope with biological relevance.
T
he resolution of an acute, sublethal infection with the facultative intracellular bacterium Listeria monocytogenes, and the subsequent long-lasting immunity to lethal infection have been characterized as classic examples of cell-mediated immunity (1). A number of studies have dearly demonstrated that adoptive transfer ofT cells from immune donors, before or shortly after L. monocTtogenes infection of mice, can result in protection against bacterial replication in target organs such as spleen or liver (2) (3) (4) . CD8 + T cells are the most effective T cell subset in these protection assays (5-10). As first proposed by Mackaness (11) , T cells are thought to protect against intracellular bacteria by a mechanism involving activation of the microbiddal activities of macrophages after antigen-driven lymphokine release. Evidence for this mechanism in L. monocxtogenes infection is based primarily on macrophage accumulation in target organs (12), the effectiveness of in vivo "ylFN treatment against L. monocytogenes infections (13, 14) , and the exacerbation of disease in mice treated with neutralizing mAb to ~/IFN (15) . However, recent reports suggest that 3'IFN secretion by CD4-8-cells may also play a role in resistance to L. monocxtogenes infection (16, 17) . The role of cytokine release by CD8 + T cells in resolution of listeriosis has not been directly addressed, and a recent study questions the requirement for 3,IFN in resolution of infection (18) . Thus, CD8 § T cell-mediated cytotoxicity against L. monocytogenes infected cells may function as a mechanism of protection in vivo, although in vivo lysis by CD8 + T cells has not been directly demonstrated.
In contrast to the body of evidence supporting a role for T cells in immunity to L. monocytogenes, several recent reports involving T cell subset depletion in vivo have questioned the role of CD8 + T cells in resolution of acute listeriosis and the relevance of the adoptive transfer assay within this context (16, 17, 19) . In these studies, bacteria were cleared from the livers of infected mice with only slightly delayed kinetics in animals depleted of CD4 + and CD8 + T cells, suggesting that early 3,IFN production by CD4-8-NK cells or q//6 T cells may be critical in clearance of bacteria from this organ. However, similar studies by other investigators have shown that T cell-depleted mice (14) and mice with the SCID mutation (20) fail to completely resolve L. monocytogenes infection, suggesting a role for T cells in this process. In the absence of further information, the simplest interpretation of these data suggests that many facets of the immune response may contribute to host defense against acute, sublethal L. monocytogenes infection, and that natural immunity clearly plays a role in resolution of sublethal infection. Despite these conflicting results regarding the cells responsible for resolution of acute listeriosis, it is clear that previously sensitized T cells are capable of enhancing the protective capacity of natural immunity to L. monocytogenes infection in vivo.
To better understand protective CD8 + T cell immunity to intracellular bacteria, further information is needed regarding the nature and number of bacterial proteins recognized through the endogenous antigen processing and presentation pathway. L. monocytogenes is a complex organism, producing perhaps 4,000 protein products with differentially regulated expression. Under these drcumstances, identification of the proteins contributing to class I MHC-restricted, immunogenic peptide epitopes is a complex undertaking. The use of gene transfection technology allowed us to identify listeriolysin O (LLO) 1 as a target molecule for H-2K arestricted CD8 + T ceils derived from L. monocytogenesinfected mice (21) . LLO is a sulflaydryl (SH)-activated cytotoxin secreted by virulent L. monocytogenes that permits entry of the organism into the cytoplasm of eukaryotic cells from the endocytic pathway (reviewed in 22). LLO secretion is necessary for L. monocytogenes to induce protective immunity in vivo (10), and to elidt 3'IFN production from specific CD8 + T cells in vitro (23) . Heat-killed organisms and organisms mutant in LLO production are incapable of indudng these responses (10, 23, 24). These observations have suggested a modal in which the requirement for LLO secretion for the induction of protective immunity is based on access of the bacterium to the cytoplasm of the infected cell (23) . Cytoplasmic localization is sufficient to introduce bacterial proteins into the class I MHC antigen processing pathway (25) , resulting in the potential for CD8 + T cell recognition. Recent advances in biochemical characterization of class I MHC bound peptides have determined that individual class I alleles bind peptides of defined length that contain anchor residues of defined composition and spacing (26) (27) (28) . The motif identified for H-2K a (27, 29) has allowed identification of a naturally produced nonamer epitope recognized by LLO-specific CD8 + T cells (21) . Since this epitope is presented by H-2K a molecules in infected mice, it has the potential for relevance in immunity to L. monocytogenes. In this study, we report the derivation of CD8 + T cell lines with spedficity for the identified LLO epitope and the in vivo biological activity of these T cell lines.
Materials and Methods
Mice. Young female adult DBA/2J and Balb/cByJ mice were obtained from The Jackson Laboratories (Bar Harbor, ME).
Bacteria. L. monocytogenes strain 43251 was grown in trypticase soy broth (TSB, Becton Dickinson & Co., Cockeysviile, MD) to log phase, and aliquots were frozen and stored at -700C. Freshly thawed bacterial stocks were allowed to return to log phase by incubation at 37eC for 3-4 h, and the bacteria were adjusted to the appropriate dilution for intravenous injection in 0.2 ml PBS. The LDs0 of this strain of L. monocytogenes for DBA/2J mice is <5 x 103 CFU/animal.
mAbs. SF1-1.1 is a mouse IgG2a mAb specific for H-2K a obtained from American Type Culture Collection (ATCC, Rockvilh, MD). Culture sup~ and protein G-(Pharmacia Fine Chemicals, Hscataway, NJ) purified mAb were used in blocking experi-1 Abbra, iations used in this paper. LLO, listeriolysin O; SH, sulfhy&yl; TSB, trypticase soy broth. merits. 34-4-20s is a mouse IgG2a mAh, and 34-4-21s a mouse IBM mAb, both of which are specific for H-2IY. These mAbs were obtained from ATCC, and both were used in the form of culture supernatant in blocking experiments. 3.168 is a rat anti-mouse mAb specific for CD8 (30) and was used to direct complement-mediated lysis of the CD8 ~ T cell lines.
Acid Extraction of MHC Class I Bound Peptides from L. monocytogenes-infected Spleens. .Acid extraction of dams I MHC bound peptides from 44-h L. monocyto&enes-~ spleens was performed as described previously, except that DBA/2 mice were infected with 50 LDs0 (21) . Briefly, spleens were harvested from infected animals and homogenized in 0.1% TFA. After 30-min incubation at 4~ insoluble material was removed by ultracentrifugation for 35 rain at 180,000 g. Soluble material <10,000 molecular weight was recovered after lyophilization and centrifugation of the resuspended material through centricon 10 columns (Amicon, Beverly, MA), and was subjected to reverse phase FIPLC using the previously described conditions. Fractions were recovered, and prepared for analysis in CTL assays as described (21) .
Priming Mic~ CD8 + T cell line 479-2 was derived from DBA/2 mice that were infected intravenously with a sublethal dose of L. monocytogenes (5 x 102 CFU) 7 d before spleen harvest and in vitro stimulation. CD8 + T cell line 603-1-2 was derived from DBA/2 mice that had been immunized 10 d earlier by intravenous injection of 2 x 107 irradiated (2,000 rad) syngeneic spleen ceils that had been incubated for I h at 370C with 1/~M LLO 91-99 peptide in RPMI 1640 with 10% FCS and 50/~M 2-ME (RP10), and then washed three times in RP10.
Tumor Cells and Target Cells for CTL Assays. The target cells used in this study were the dams II MHC-negative P815 (DBA/2, H-2 a) mastocytoma and various transfectants of P815. Derivation of the LLO transfectant of P815, PHem3 has been described (21). PHem3.3 is a subclune of PHem3 derived by limit dilution, while PBAc-1 is P815 transfected with the parental pFI~APr-l-neo vector (31) without insert. P13.4 is P815 transfected with the Escherichia coli/~-galactosidase gene (32) . ) at 370C in 7% CO2/air. Subsequent weekly restimuhtions were carried out with 2.5 x 106 responder cells, 2-3 x 106 irradiated PHem3.3 ceils, and 35 x 106 irradiated (2,000 tad) syngeneic spleen ceils in 20 ml RP10 containing 5% supernatant from Con A-stimulated rat spleen cells and 50 raM ~-methyl mannoside in upright 25-cra 2 flasks. The 0805B CD8 + T cell line was a gift of H.-G. Rammensee and is specific for E. coli t~-galactosidase in the context of H-2L a (33). 0805B was maintained in analogous fashion to the LLO specific lines except that the stimulators were P13.4 ceils.
In Vitro Stimulation of Effectors and Long-Term CD8 § T Cell
CTL Assay. Target ceils (106) in 300/~1 RP10 were hbeled with 100/~Ci [SlCr]sodium chromate for 1 h at 37~ After washing, 104 target ceils were incubated with serial dilutions of effector ceils in 200/tl of R.Pl0 in round bottomed 96-well plates. The synthetic peptide representing LLO 91-99 (single letter code GYKDGNEYI) was added to the target ceils just before their addition to the wells. In vitro targeting activity of HPLC fractions was assessed using 50 tzl of each resuspended fraction, 104 target cells, and the indicated number of effector CTL in 200/~1 RP10. After 3-4 h incubation at 370C, 100 td supematant was collected and specific lysis was determined as: pesv.ent specific lysis = 100 x [(release by CTL -spontaneous rdease)/(maximum release -spontaneous release)]. Spontaneous release in the absence of CTL was <10% in all experiments.
In Vivo Protection Assall. CD8 § T cell lines were harvested at day eight or nine after stimulation and were washed twice in PBS before intravenous injection in 0.2 ml. Animals were infected 30 min later by intravenous injection of 5 x 10 ~ L. monocytogenes (>1 LDs0) in 0.2 ml PIGS. Organs were harvested 48 or 72 h after infiction and were homogenized (UItra-Turrax; Tekmar Co., Cincinnati, OH) in sterile distilled water containing 0.2% NP-40. Splenic homogenates were performed in a 5 ml volume, while Liver homogenates were performed in 10 ml. Homogenates were incubated at room temperature for 30 rain and serial 10-fold dihtions were made in 0.2% NP-40. ALiquots of relevant dilutions were plated on TSB-agar, incubated 18-24 h, and the colonies enumerated. Colony counts from each series were corrected for dilution and averaged to yield CFU/organ. Detection Limits were 50 CFU/spleen and 100 CFU/Liver. Student's t test was employed in the analysis of results. Each group consisted of three animals, and each experiment was performed at least twice with similar results.
Results

Generation of LLO.specific COS + T Cells from Infected M/c~
The LID-expressing P815 transfectant, PHem3, is recognized by CD8 + T cells derived from L. monocytogenesinfected H-2 a mice, and a nonarner peptide presented by H-2K d has been identified as a target epitope (21) . To assess the biological relevance of a CD8 + T cell response to this protein, we sought to derive CD8 + T ceil lines with specificity directed solely against LLO. DBA/2 (H-2 a) mice were sublethaUy infected with 5 x 102 L. monocytogenes via intravenous injection, and their spleen ceils were harvested 7 d hter and stimulated in vitro with the MHC dass II-negatire PHem3 transfectant, or a subdone designated PHem3.3. After several rounds of in vitro stimulation, a CD8 + T cell line designated 479-2 was found to specifically lyse the LLO transfectant PHem3.3 and not the P815 cells transfected with the parental vector ( In Vivo Protection b 7 the LLO-Specific CD8 + T Cells. LLO is a secreted protein required for L. monocytogenes entry into the cytoplasm of the infected cell (reviewed in 22). As such, it is likely to be one of the first bacterial proteins accessible to the class I MHC antigen processing pathway and thus, one of the first bacterial proteins to provide epitopes presented at the ceil surface during infection. In addition, dass I MHC presentation of LID epitopes should be independent of the need for bacterial destruction in the infected ceils. Under these drcumstances, a CD8 + T cell response to this protein might be effective at an early stage of L. monocytogenes infection. We addressed this question by infusing line 479-2 into syngeneic DBA/2 mice just before infection of the mice with >1 LDs0 of L. monocytogenes. Using this type of protocol, previous experiments have shown that CD8 + T cells from immunized mice (5-10) or a MHC-urtrestricted CD8 + T cell done specific for L. monocytogenes (34) are effective in protection from bacterial replication in spleen and liver. However, these studies have not provided information regarding the nature of the bacterial protein(s) contributing the relevant epitopes in the protective response. Fig. 2 illustrates the results of such an experiment with the LID-specific line in which injection of 15 x 10 s 479-2 CD8 + T cells just before infection of DBA/2 mice with >1 LDs0 of L. monocytogenes reduced the bacterial load by >3 logw in spleens, 
(Fig. 1). However, additional specificities for other epitopes have not been completely ruled out. Antibody blocking of line 479-2 lysis of the LLO transfectant indicates that lysis is inhibited only by anti-H-2K a antibodies as was demonstrated with recognition of LID 91-99 (data not shown) (21).
To determine whether other epitopes might be recognized by this line, peptides were acid extracted from DBA/2 spleens 44 h after infection with 50 LDs0 of L. monocytogenes and separated by reverse phase HPLC as previously described (21). Line 479-2 reactivity was confined to a single peak with maximal targeting activity in HPLC fraction 28, which has previously been identified as the fraction containing LLO 91-99 (21) (Fig. 4) . While these data do not rule out reactivity to other LLO peptides that may have identical elution characteristics, they do strongly suggest, in conjunction with the ability of line 479-2 to very effldently lyse P815 cells incubated and by >1.5 log10 in livers, with respect to control mice. The protective ability of the 479-2 CD8 + T cells was dose dependent (Fig. 3 A) and specific since the H-2a-derived CD8 + T cell line 0805B, which is specific for E. coli 3-galactosidase in the context of H-2L d (33), had no protective effect (Fig. 3, B 
Generation of LLO 91-99-Specific CD8 + T Cells by Peptide Immunization.
To further determine whether the protective activity of LLO-specific CD8 + T cells in vivo is due to recognition of LEO 91-99, CD8 + T cell lines were derived from peptide-immunized mice. Responder cells were spleen cells obtained from DBA/2 mice that had been immunized 10 d earlier by intravenous injection of irradiated syngeneic spleen cells that had been incubated with 1 #M LEO 91-99 at 37~ followed by extensive washing. Line 603-1-2 was derived from peptide-immunized mice stimulated in vitro with the LEO transfectant, and specifically lysed the PHem3.3 cells, as well as the transfectant control cells in the presence of synthetic LEO 91-99, but did not recognize the transfectant control cells alone (Fig. 6) . Line 603-1-2 was >97% CD8 + by FACS | analysis (data not shown).
In Vivo Protection by CD8 § T Cells Derived from Peptideimmunized Mice. CD8 + T cell line 603-1-2 should have specificity only for the LEO 91-99 epitope because of the in vivo peptide immunization protocol used. Naive spleen cells stimulated in vitro with PHem3.3 exhibited no response to the transfectant or the transfectant control cells (data not shown). It has been observed that CD8 + T cells derived by in vitro stimulation with peptides often will not recognize endogenously processed and presented antigen despite their ability to recognize peptide-coated targets (35, 36) . Stimulation of the LEO 91-99 peptide-immune spleen cells in vitro with the LEO transfectant was carried out to expand CD8 + T cells with the ability to recognize endogenously presented antigens.
The LLO 91-99-specific CD8 + T cell line 603-1-2 is capable of protecting DBA/2 mice from L. monocytogenes replication, reducing bacterial growth in both the spleens and livers of mice infected with >1 LDs0 (Fig. 7) . In addition, line 603-1-2 is capable of inhibiting L. monocytogenes replication in both spleens and livers of mice infected with >1 LDso when the CD8 § T cells are administered as late as 24 h after infection, reducing bacterial titers by >1 log10 and >1.5 logt0, respectively (Fig. 8) . In contrast, multi-epitopespecific T cells obtained from immune donors 6 d after infection have been found ineffective when injected 24 h postinfection (19) . These data confirm that in vivo protection against L. monocytogenes can be mediated by CD8 § T cells with specificity for LLO 91-99, and clearly demonstrate that peptide immunization in vivo can elicit cells with protective caparty after in vitro stimulation with endogenously processed and presented antigen.
Discusaion
CD8 + T cell-mediated immunity to L. monocytogenes has been hypothesized to result from antigen-specific release of T cell-derived lymphokines, resulting in activation of macrophages (37, 38) . However, the target protein(s) for this response have not been defined. In this report, we have demonstrated that a single, naturally produced epitope of nine amino acids in the LLO molecule can elicit CD8 + T cell responses capable of inhibiting L. monocytogenes replication in H-2 d mice. In addition, we have shown that LLO 91-99-specific CD8 + T cells can reduce bacterial replication in target organs when injected 24 h after infection. This result is in contrast to the reported inability of T cells obtained from 6-d infected animals to affect L. raonocytogenes replication when injected 24 h after infection (19) . The latter experiments were performed in H-2 bxa mice that have been shown to recognize LLO 91-99 (21) . It is likely that the differences in these data result from differences in the number of LLO 91-99-specific CD8 + T cells injected. These data do not imply that the in vitro expanded CD8 + T cells described in this study are more effldent in protection than multi-epitope-specific immune spleen cells, but do suggest that a substantial immune response to a single nonamer epitope can affect L. raonocy~genes replication even after 24 h of infection.
The protective CD8 + T cell responses were obtained after in vitro stimulation of immune spleen cells with a transfectant expressing the LLO molecule that is a secreted protein produced early in the intracellular infection by virulent L. monocytogenes (reviewed in 22). Thus, these experiments identify a dass of bacterial proteins, those secreted by the organism during intracellular growth, as target proteins for protective CD8 + T cell-mediated immunity. The results are consistent with the view that any protein reaching the cytoplasm of an eukaryotic cell may be accessible to the class I MHC antigen processing pathway (25) . In addition, a potentially important feature of epitopes derived from secreted bacterial proteins is that they are likely to be presented early in the infection of a cell. While our experiments do not address the mechanism of protection by the LLO 91-99-spedfic CD8 + T cells, early recognition of the infected cell by CD8 + T cells could possibly expand the spectrum of effective immunity to include lytic events, as well as the role for 3,IFN/lymphokine production and macrophage activation. Under both of these scenarios, the immune CD8 + T cells could function to effectively convert a lethal infection into a sublethal infection. This situation could then be dealt with via the components of the natural immune response to L. monocytogenes that are intact and contributing to the resolution of infection in the protected animals. In contrast, dass I MHC-restricted presentation of epitopes derived from nonsecreted proteins may require intracellular death and degradation of the organisms after their entry into the cytoplasm. These events may be relatively rare since 3,IFN-activated macrophages apparently prevent L. monocytogenes from exiting the endocytic vacuole (39) , and the organism may be degraded without access to the cytoplasm in these cells. One testable hypothesis generated by these suggestions is that protective CD8 + T cell immunity may be specific for epitopes found only in secreted proteins from L. monocytogenes.
The ability of single epitope-spedfic CD8 + T cell responses to protect against intracdlular pathogens other than viruses is somewhat controversial. In the L. monocytogenes system, a MHC unrestricted CD8 + T cell clone has been shown to have some protective effect in vivo, but the singleepitope specificity of the done was not rigorously demonstrated, and this clone required in vivo administration of fib2 for effectiveness (34) . Thus, the nature of the recognition event in this protection experiment was undefined. In the mouse mode! of Plasraodiura berghei infection, some circumsporozite-coat protein-specific CD8 + T cell dones obtained by in vitro stimulation with peptides were effective in vivo and some were not, despite having reactivity to the same 12 amino acid peptide (40) , a finding that may be explained by downmodulation of appropriate homing receptors on some dunes (41) , or by isolation of peptide-specific dones that could not recognize endogenously presented antigen (35, 36) . In addition, repetitive immunization of mice with a transfectant expressing a single Plasmodium faki~rura coat protein yielded only partial protection, whereas immunization with two transfectants expressing different coat proteins resulted in complete protection (42) . The failure to generate a protective response after immunization can result either from the failure to dicit specific T cells, or from the inability of the didted T cells to affect the outcome of the infection. Our results indicate that LLO 91-99-specific CD8 + T cell lines generated from infected mice, or mice immunized with a synthetic peptide derived from the identified natural epitope are capable of mediating protection against L. monocytogenes replication in infected mice. Analysis of the response of single epitope-specific T cell lines composed of oligodonal populations of responder cells may better reflect the in vivo response to antigen and its biological consequences than the response of individual T cell clones. As we have shown, it is dearly feasible to generate single epitope-specific, highaffinity CD8 + T cell lines using a combination of peptide immunization and in vitro stimulation with endogenously processed and presented antigen. This approach overcomes problems with peptide restimulations in vitro that can result in CD8 + T cells capable of lysing peptide-coated cells, but that often fail to recognize endogenously presented antigen (35, 36) , although exceptions exist at the donal level (43) . Using this immunizationAtimulation approach we have determined that recognition of LLO 91-99 is relevant to protection against L. monocytogenes, and that LLO 91-99 may be a candidate epitope for analysis of the conditions required for eflident peptide vaccination against intracellular pathogens.
LLO 91-99 was identified using the allde-specific motif for H-2K a (21) . In this report, we have extended this approach to determine that the identified epitope has the potential to elicit CD8 + T cell responses capable of significantly
